43 reports of this reaction
2.5% of all PYRITHIONE ZINC reports
#5 most reported adverse reaction
HEADACHE is the #5 most commonly reported adverse reaction for PYRITHIONE ZINC, manufactured by Wal-Mart Stores Inc. There are 43 FDA adverse event reports linking PYRITHIONE ZINC to HEADACHE. This represents approximately 2.5% of all 1,712 adverse event reports for this drug.
Patients taking PYRITHIONE ZINC who experience headache should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
HEADACHE is a less commonly reported adverse event for PYRITHIONE ZINC, but still significant enough to appear in the safety profile.
In addition to headache, the following adverse reactions have been reported for PYRITHIONE ZINC:
The following drugs have also been linked to headache in FDA adverse event reports:
HEADACHE has been reported as an adverse event in 43 FDA reports for PYRITHIONE ZINC. This does not prove causation, but indicates an association observed in post-market surveillance data.
HEADACHE accounts for approximately 2.5% of all adverse event reports for PYRITHIONE ZINC, making it a notable side effect.
If you experience headache while taking PYRITHIONE ZINC, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.